[1]
Aladhab, R.A. 2026. Association of empagliflozin treatment with changes in the metabolic score for insulin resistance in Iraqi adults with type 2 diabetes: a 6-month prospective cohort study. International Journal of Basic & Clinical Pharmacology. (Aug. 2026). DOI:https://doi.org/10.18203/2319-2003.ijbcp20262782.